XML 44 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Shareholders' Equity (Deficit): (Tables)
12 Months Ended
Dec. 28, 2024
Shareholders' Equity (Deficit):  
Schedule of stock option activity

    

    

    

Weighted Average

    

Remaining

Number of

Weighted Average

Contractual Life

Shares

Exercise Price

(years)

Intrinsic Value

Outstanding, December 25, 2021

 

355,621

$

146.03

 

Granted

 

62,540

217.03

Exercised

 

(50,032)

94.97

Forfeited

(6,501)

183.28

Outstanding, December 31, 2022

 

361,628

164.70

 

Granted

 

21,320

328.68

Exercised

 

(37,304)

107.49

Forfeited

(3,752)

204.26

Outstanding, December 30, 2023

 

341,892

180.73

Granted

 

25,300

377.63

Exercised

 

(42,767)

117.70

Forfeited

 

(4,581)

239.61

Outstanding, December 28, 2024

 

319,844

$

203.89

5.72

$

61,841,500

Exercisable, December 28, 2024

 

233,931

$

173.68

4.82

$

52,073,200

Schedule of weighted average assumptions used in estimation of fair value of options granted

Year Ended

 

    

December 28, 2024

December 30, 2023

    

December 31, 2022

 

Risk free interest rate

 

4.34

%

3.88

%

3.15

%

Expected life (years)

 

6

6

6

Expected volatility

 

29.13

%

28.10

%

27.58

%

Dividend yield

 

2.84

%

2.94

%

4.29

%

Option fair value

$

98.64

$

79.88

$

40.59